BioCentury
ARTICLE | Finance

Banker tracks

Biotech investor, banker and analyst personnel changes

April 14, 2014 7:00 AM UTC

Adam Koppel departed Brookside Capital as a managing director and will become SVP and chief strategy officer at Biogen Idec Inc. (NASDAQ:BIIB) on May 15.

Kern Wildenthal joined Satori Capitalas an operating partner focused on healthcare. Wildenthal was president of the University of Texas Southwestern Medical Center...